We are live on ! Find out more
WA

WuXi AppTec Portfolio holdings

AUM $19M
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+26.38%
1 Year Est. Return
+20.22%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$29.4M
AUM Growth
-$9.17M
Cap. Flow
-$15.3M
Cap. Flow %
-52.02%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
1
Closed
3

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
AMAM
Ambrx Biopharma Inc
AMAM
+$14.2M
2
ADAG
Adagene
ADAG
+$756K
3
PPBT
Purple Biotech
PPBT
+$151K
4
CSTL icon
Castle Biosciences
CSTL
+$143K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LYEL icon
1
Lyell Immunopharma
LYEL
$336M
$18.2M 62.06%
409,034
– –
ADAG
2
Adagene
ADAG
$246M
$11.2M 37.94%
3,982,902
-242,794
-6% -$756K
CSTL icon
3
Castle Biosciences
CSTL
$813M
– –
-6,636
Closed -$143K
PPBT
4
Purple Biotech
PPBT
$1.28M
– –
-971
Closed -$151K
AMAM
5
DELISTED
Ambrx Biopharma Inc
AMAM
– –
-1,000,000
Closed -$14.2M

Similar funds

TOTSC
Trustees of the Smith College Northampton, Massachusetts $18.3M AUM 20.14% 1-Year Est. Return
RPA
Rose Park Advisors Boston, Massachusetts $17.5M AUM 44.41% 1-Year Est. Return
SIIG
SC Israel IV Genpar Herzelia, Israel $17.5M AUM
UID
Union Investments & Development Tel Aviv, Israel $17.3M AUM 20.08% 1-Year Est. Return
OCM
Oakview Capital Management Dallas, Texas $21.6M AUM 20.25% 1-Year Est. Return
KLM
Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return
CMG
Cavalry Management Group San Francisco, California $22.3M AUM 65.95% 1-Year Est. Return

WuXi AppTec's Q1 2024 Portfolio in Review

As of Q1 2024, WuXi AppTec held 5 positions worth $29.4M, down 24% from $38.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

WuXi AppTec withdrew a net $15.3M in Q1 2024, closing 3 positions and reducing 1 holding. Its most notable exit was Ambrx Biopharma Inc, an estimated $14.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • WuXi AppTec's biggest Q1 2024 reduction was Adagene, cutting an estimated $756K.
  • WuXi AppTec fully exited Ambrx Biopharma Inc in Q1 2024, selling an estimated $14.2M.
  • WuXi AppTec's ten largest holdings make up 100% of its $29.4M portfolio in Q1 2024.
  • WuXi AppTec opened 0 new positions and closed 3 in Q1 2024.
  • WuXi AppTec's portfolio value fell 24% quarter-over-quarter to $29.4M.

Based on WuXi AppTec's 13F filing for Q1 2024, filed 7 May 2024.